600993.SH
马应龙
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.73
−1.22%Margins
Gross margin
48.8%
EBITDA margin
20.2%
EBIT margin
18.6%
Net margin
15.1%
FCF margin
15.2%
12.9%
Return on equity
10.5%
Return on assets
15.6%
Return on invested capital
0.71x
Asset turnover
CNY 685.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026